<PlanDefinition xmlns="http://hl7.org/fhir">
	<id value="plandefinition-ANCRecommendationC6"/>
	<meta>
		<profile value="http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-recommendationdefinition"/>
	</meta>
	<url value="http://fhir.org/guides/who/anc/PlanDefinition/plandefinition-ANCRecommendationC6"/>
	<identifier>
		<use value="official"/>
		<value value="PlanDefinition_ANCRecommendationC6"/>
	</identifier>
	<version value="0.1.0"/>
	<name value="PlanDefinition_ANCRecommendationC6"/>
	<title value="PlanDefinition - WHO ANC Guideline Recommendation C.6"/>
	<type>
		<coding>
			<system value="http://terminology.hl7.org/CodeSystem/plan-definition-type"/>
			<code value="eca-rule"/>
			<display value="ECA Rule"/>
		</coding>
	</type>
	<status value="draft"/>
	<experimental value="true"/>
	<date value="2019-05-15"/>
	<copyright value="Â© WHO 2019+."/>
	<library value="http://fhir.org/guides/who/anc/Library/ANCRecommendationC6"/>

	<action>
		<title value="Recommend IPTp-SP"/>
		<trigger>
			<type value="named-event"/>
			<name value="anc-contact"/>
		</trigger>
		<condition>
			<kind value="applicability"/>
			<expression>
				<language value="text/cql.identifier"/>
				<expression value="IPTp-SP Dose Due"/>
			</expression>
		</condition>
		<title value="IPTp-SP Dose Due"/>
		<textEquivalent value="In malaria-endemic areas in Africa, intermittent preventive
		treatment with sulfadoxine-pyrimethamine (IPTp-SP) is recommended for all pregnant
		women. Dosing should start in the second trimester, and doses should be given at
		least one month apart, with the objective of ensuring that at least three doses
		are received."/>
		<definitionCanonical value="http://fhir.org/guides/who/anc-cds/ActivityDefinition/activitydefinition-anc-iptp-sp"/>
	</action>
</PlanDefinition>
